×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Minimally Invasive Surgery Devices Market

ID: MRFR/HC/48814-HCR
200 Pages
Rahul Gotadki
October 2025

China Minimally Invasive Surgery Devices Market Research Report By Application (General Surgery, Cardiothoracic Surgery, Gynecological Surgery, Urological Surgery, Orthopedic Surgery), By Product Type (Endoscopes, Robotic Surgery Systems, Laparoscopic Surgical Instruments, Visualization Systems, Access Devices), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Technology (Video-Assisted Thoracoscopic Surgery, Transcatheter Aortic Valve Replacement, Natural Orifice Transluminal Endoscopic Surgery) -Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Minimally Invasive Surgery Devices Market Infographic
Purchase Options

China Minimally Invasive Surgery Devices Market Summary

As per Market Research Future analysis, the China minimally invasive-surgery-devices market Size was estimated at 1381.86 USD Million in 2024. The China minimally invasive-surgery-devices market is projected to grow from 1508.99 USD Million in 2025 to 3638.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 9% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China minimally invasive-surgery-devices market is experiencing robust growth driven by technological advancements and increasing patient awareness.

  • Technological advancements are enhancing the efficacy and safety of minimally invasive surgical procedures.
  • The largest segment in this market is the laparoscopic devices segment, while the fastest-growing segment is the robotic-assisted surgery devices segment.
  • Rising patient awareness regarding the benefits of minimally invasive surgeries is contributing to market expansion.
  • Key market drivers include the increasing demand for surgical efficiency and the aging population coupled with rising chronic diseases.

Market Size & Forecast

2024 Market Size 1381.86 (USD Million)
2035 Market Size 3638.0 (USD Million)
CAGR (2025 - 2035) 9.2%

Major Players

Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

China Minimally Invasive Surgery Devices Market Trends

The minimally invasive-surgery-devices market is experiencing notable growth, driven by advancements in technology and increasing demand for less invasive surgical procedures. In recent years, there has been a shift towards techniques that minimize patient recovery time and reduce hospital stays. This trend is largely influenced by the rising awareness among patients regarding the benefits of minimally invasive surgeries, such as reduced pain and scarring. Furthermore, the aging population in China is contributing to a higher prevalence of chronic diseases, which in turn fuels the need for innovative surgical solutions. As healthcare providers adopt new technologies, the market is likely to expand, offering a variety of devices that cater to diverse surgical needs. In addition, the regulatory environment in China appears to be evolving, with authorities focusing on enhancing the approval processes for medical devices. This could potentially lead to a more streamlined pathway for new products entering the market. Moreover, the increasing investment in healthcare infrastructure is expected to support the growth of the minimally invasive-surgery-devices market. As hospitals and clinics upgrade their facilities, the demand for advanced surgical tools is likely to rise, further propelling market expansion. Overall, the combination of technological advancements, demographic shifts, and regulatory improvements suggests a promising outlook for the minimally invasive-surgery-devices market in the near future.

Technological Advancements

The minimally invasive-surgery-devices market is witnessing rapid technological innovations. Enhanced imaging techniques, robotic-assisted surgeries, and improved surgical instruments are transforming the landscape. These advancements not only improve surgical precision but also enhance patient outcomes, making procedures safer and more efficient.

Rising Patient Awareness

There is a growing awareness among patients regarding the benefits of minimally invasive procedures. Patients are increasingly seeking options that offer quicker recovery times and less postoperative discomfort. This trend is driving demand for devices that facilitate such surgeries, influencing market dynamics.

Regulatory Changes

The regulatory framework governing medical devices in China is undergoing significant changes. Authorities are streamlining approval processes, which may lead to faster market entry for innovative minimally invasive-surgery devices. This shift could encourage more companies to invest in research and development, further stimulating market growth.

China Minimally Invasive Surgery Devices Market Drivers

Technological Integration in Healthcare

The integration of advanced technologies into healthcare practices is reshaping the minimally invasive-surgery-devices market. Innovations such as robotic-assisted surgery and enhanced imaging techniques are becoming more prevalent in Chinese hospitals. These technologies not only improve precision during surgical procedures but also enhance the overall safety and effectiveness of operations. The market for robotic surgical systems alone is anticipated to reach $1 billion by 2026 in China, reflecting a growing investment in cutting-edge surgical technologies. This trend indicates a shift towards more sophisticated surgical methods, which could potentially revolutionize patient care.

Increasing Demand for Surgical Efficiency

The demand for enhanced surgical efficiency is a primary driver in the minimally invasive-surgery-devices market. Surgeons and healthcare facilities in China are increasingly seeking methods that reduce operation time and improve patient outcomes. Minimally invasive techniques, which often result in shorter recovery periods and less postoperative pain, are becoming the preferred choice. According to recent data, the market for these devices is projected to grow at a CAGR of approximately 10% over the next five years. This growth is indicative of a broader trend towards optimizing surgical procedures, which is likely to continue as healthcare providers strive to improve operational efficiency and patient satisfaction.

Aging Population and Rising Chronic Diseases

China's aging population is a significant factor influencing the minimally invasive-surgery-devices market. As the demographic shifts towards an older population, the prevalence of chronic diseases such as cardiovascular conditions and diabetes increases. This demographic trend necessitates more surgical interventions, many of which can be performed using minimally invasive techniques. The World Health Organization estimates that by 2030, the number of individuals aged 60 and above in China will reach 487 million, further driving the demand for advanced surgical solutions. Consequently, the market is expected to expand as healthcare systems adapt to the needs of an aging society.

Government Initiatives and Healthcare Investments

Government initiatives aimed at improving healthcare infrastructure are playing a crucial role in the growth of the minimally invasive-surgery-devices market. The Chinese government has been increasing its healthcare budget, with a focus on modernizing hospitals and expanding access to advanced medical technologies. In 2025, the healthcare expenditure is projected to reach approximately $1 trillion, which will likely facilitate the adoption of minimally invasive surgical techniques. This investment not only enhances the availability of these devices but also encourages research and development, fostering innovation within the market.

Rising Healthcare Expenditure and Insurance Coverage

The increase in healthcare expenditure in China is a significant driver for the minimally invasive-surgery-devices market. As disposable incomes rise, patients are more willing to invest in advanced medical treatments. Furthermore, the expansion of health insurance coverage is making minimally invasive procedures more accessible to a broader population. Reports indicate that healthcare spending in China is expected to grow by 6% annually, which will likely support the adoption of minimally invasive surgical techniques. This trend suggests a shift towards prioritizing quality healthcare, thereby enhancing the market's growth potential.

Market Segment Insights

By Application: General Surgery (Largest) vs. Cardiothoracic Surgery (Fastest-Growing)

The China minimally invasive-surgery-devices market is characterized by diverse applications, with General Surgery commanding the largest market share. This segment benefits from a broad range of procedures, catering to various surgical needs which contributes to its dominance. Following closely, Cardiothoracic Surgery is seeing a significant uptick in adoption, reflecting its innovative approaches and rising prevalence of cardiological conditions. Growth trends indicate a surge in demand for minimally invasive techniques across multiple surgical domains. Factors such as increasing healthcare expenditure, advancements in surgical technology, and a growing elderly population are driving the expansion of these segments. Notably, the efficiency and reduced recovery times associated with these procedures are attracting more healthcare providers, further propelling the market.

General Surgery: Dominant vs. Cardiothoracic Surgery: Emerging

General Surgery stands as a dominant application within the China minimally invasive-surgery-devices market, featuring a wide array of procedures that incorporate state-of-the-art techniques aimed at enhancing patient outcomes. Surgeons are increasingly opting for minimally invasive methods due to their advantages in terms of lower complication rates and quicker recovery times. On the other hand, Cardiothoracic Surgery is emerging rapidly, largely due to an increase in cardiovascular diseases and the technological advancements that support minimally invasive solutions in this sensitive area. While General Surgery continues to lead, the innovative procedures in Cardiothoracic Surgery are attracting investments, suggesting that this segment could rise to prominence in the coming years.

By Product Type: Endoscopes (Largest) vs. Robotic Surgery Systems (Fastest-Growing)

In the China minimally invasive-surgery-devices market, the distribution of market share among product types reveals that endoscopes hold a significant portion of the market, primarily due to their wide application in diagnostic and therapeutic procedures. Following endoscopes, laparoscopic surgical instruments and access devices also contribute notably to the overall market landscape, however, robotic surgery systems are emerging as a key player with rapidly increasing adoption rates across healthcare facilities. Recent growth trends indicate a shift towards more advanced surgical techniques, propelled by technological advancements and increasing patient demand for minimally invasive procedures. Robotic surgery systems are gaining traction, driven by their precision and efficiency, leading to reduced recovery times for patients. Furthermore, visualization systems are playing a pivotal role in enhancing surgical outcomes, suggesting that innovation will continue to fuel market expansion in the coming years.

Endoscopes (Dominant) vs. Robotic Surgery Systems (Emerging)

Endoscopes are currently the dominant product type in the China minimally invasive-surgery-devices market, attributed to their extensive use in minimally invasive diagnostics and therapeutics. They offer benefits such as shorter recovery times, reduced patient discomfort, and lower risks of complications. On the other hand, robotic surgery systems are recognized as an emerging segment with significant growth potential, driven by advancements in robotic technology that enable surgeons to perform more complex procedures with enhanced precision. While endoscopes currently lead in market share, the shift towards robotic systems indicates a transformative phase in the medical landscape as hospitals seek to adopt cutting-edge technologies for improved patient outcomes and operational efficiencies.

By End-use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the China minimally invasive-surgery-devices market, hospitals hold the largest share among end-use segments, reflecting their extensive utilization of these advanced surgical techniques. Ambulary surgical centers are close behind but are rapidly catching up due to the growing preference for outpatient procedures, which are more convenient and cost-effective for patients. Specialty clinics, while important, represent a smaller portion of the overall market share, focusing mainly on niche surgical areas and specialized treatments. The growth trends within this segment are prominently driven by an increasing demand for minimally invasive procedures across hospitals and ambulatory surgical centers. Technological advancements and improvements in surgical instruments continue to push the boundaries of these procedures’ capabilities. Factors such as population aging and the rising prevalence of chronic diseases are also contributing to the strong growth outlook, as more patients seek effective and less invasive treatment options.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals, as the dominant end-use segment, benefit from comprehensive facilities and a wide range of surgical specialties, enabling them to offer extensive minimally invasive surgeries. They are equipped with advanced technologies and skilled professionals, thus fostering greater patient trust. Ambulatory surgical centers, on the other hand, are emerging rapidly, appealing to patients seeking outpatient solutions with quicker recovery times. These centers typically focus on specific types of surgeries, which allows them to streamline processes and reduce costs. Their growth is further supported by shifts in patient preferences and healthcare policies promoting outpatient care, positioning them as a significant player in the China minimally invasive-surgery-devices market.

By Technology: Video-Assisted Thoracoscopic Surgery (Largest) vs. Transcatheter Aortic Valve Replacement (Fastest-Growing)

In the China minimally invasive-surgery-devices market, Video-Assisted Thoracoscopic Surgery (VATS) holds the largest market share due to its widespread adoption in various thoracic procedures. This segment accounts for a significant portion of market activity, largely driven by advancements in technology and increasing popularity among surgeons. Transcatheter Aortic Valve Replacement (TAVR) is also gaining traction and represents a growing segment as it provides a less invasive alternative for patients with aortic valve stenosis. The growth trends in this segment are largely influenced by the rising demand for minimally invasive procedures that reduce patient recovery time and improve outcomes. Innovations in device technology, along with increased investments in research and development, are further propelling the growth of TAVR as a cutting-edge option. Additionally, the growing aging population in China is driving the need for these advanced surgical solutions, thereby enhancing market dynamics overall.

Technology: Video-Assisted Thoracoscopic Surgery (Dominant) vs. Transcatheter Aortic Valve Replacement (Emerging)

Video-Assisted Thoracoscopic Surgery (VATS) is characterized by its ability to offer less invasive options for patients, enabling quicker recoveries and less postoperative pain. As the dominant technology in the segment, it showcases impressive adaptability across numerous thoracic procedures. Conversely, Transcatheter Aortic Valve Replacement (TAVR) is emerging rapidly as a preferred choice among physicians for treating aortic valve diseases. TAVR's appeal lies in its minimally invasive nature, allowing access through the femoral artery, which significantly reduces surgical risks. Both technologies exemplify the shift towards less invasive surgical options, catering to an increasing demand in the China minimally invasive-surgery-devices market.

Get more detailed insights about China Minimally Invasive Surgery Devices Market

Key Players and Competitive Insights

The minimally invasive-surgery-devices market in China is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for less invasive surgical options. Key players such as Medtronic (US), Johnson & Johnson (US), and Intuitive Surgical (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Medtronic (US) emphasizes its commitment to developing cutting-edge technologies, while Johnson & Johnson (US) leverages its extensive portfolio to cater to diverse surgical needs. Intuitive Surgical (US) continues to lead in robotic-assisted surgery, indicating a strong focus on automation and precision in surgical procedures. Collectively, these strategies contribute to a competitive environment that prioritizes technological superiority and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain resilience. This approach appears to be particularly relevant in the context of the current market structure, which is moderately fragmented, with several players vying for market share. The collective influence of these key players shapes the competitive dynamics, as they engage in strategic collaborations and innovations to capture a larger segment of the market.

In October Medtronic (US) announced the launch of a new line of minimally invasive surgical instruments designed specifically for orthopedic procedures. This strategic move is likely to enhance Medtronic's product offerings and strengthen its position in the orthopedic segment, which has been experiencing significant growth due to rising incidences of musculoskeletal disorders. The introduction of these advanced instruments may also reflect Medtronic's commitment to addressing the evolving needs of healthcare providers in China.

In September Johnson & Johnson (US) expanded its partnership with local healthcare providers to enhance access to its minimally invasive surgical solutions. This initiative is indicative of Johnson & Johnson's strategy to deepen its market penetration in China, where localized partnerships can facilitate better distribution and adoption of its innovative products. By aligning with local stakeholders, the company appears to be positioning itself to respond more effectively to regional healthcare demands.

In August Intuitive Surgical (US) unveiled a new software update for its robotic surgical systems, incorporating advanced AI capabilities to improve surgical precision and outcomes. This development underscores Intuitive Surgical's focus on integrating digital technologies into its offerings, which may enhance the overall efficiency of surgical procedures. The incorporation of AI not only positions the company as a leader in innovation but also reflects a broader trend within the industry towards digital transformation.

As of November the competitive trends in the minimally invasive-surgery-devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to meet the specific needs of healthcare providers. This evolution suggests that companies that prioritize these aspects will likely gain a competitive edge in the market.

Key Companies in the China Minimally Invasive Surgery Devices Market include

Industry Developments

Recent developments in the China Minimally Invasive Surgery Devices Market have been noteworthy, marked by significant growth in the value and adoption of minimally invasive technologies. In September 2023, Medtronic announced advancements in their robotic surgery systems tailored for the Chinese market, aiming to enhance surgical precision and patient outcomes. Olympus has also made strides with the introduction of innovative endoscopic systems that align with China's increasing emphasis on minimally invasive procedures. In the realm of mergers and acquisitions, Boston Scientific completed its acquisition of a local competitor in August 2023, broadening its footprint within the region.

The burgeoning demand has led to considerable investments from major players like Stryker and Johnson and Johnson who are actively expanding their product lines in line with the growing healthcare needs in China. In the past two years, the market has seen ongoing research collaborations and partnerships, particularly focusing on enhancing technology and innovation in surgical procedures, ensuring a robust environment for the continued evolution of minimally invasive surgery across China.

Future Outlook

China Minimally Invasive Surgery Devices Market Future Outlook

The Minimally Invasive Surgery Devices Market in China is projected to grow at a 9.2% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand.

New opportunities lie in:

  • Development of AI-driven surgical assistance tools
  • Expansion of telemedicine platforms for remote consultations
  • Investment in biodegradable surgical devices for sustainability

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

China Minimally Invasive Surgery Devices Market End-use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

China Minimally Invasive Surgery Devices Market Technology Outlook

  • Video-Assisted Thoracoscopic Surgery
  • Transcatheter Aortic Valve Replacement
  • Natural Orifice Transluminal Endoscopic Surgery

China Minimally Invasive Surgery Devices Market Application Outlook

  • General Surgery
  • Cardiothoracic Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Orthopedic Surgery

China Minimally Invasive Surgery Devices Market Product Type Outlook

  • Endoscopes
  • Robotic Surgery Systems
  • Laparoscopic Surgical Instruments
  • Visualization Systems
  • Access Devices

Report Scope

MARKET SIZE 2024 1381.86(USD Million)
MARKET SIZE 2025 1508.99(USD Million)
MARKET SIZE 2035 3638.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 9.2% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)
Segments Covered Application, Product Type, End-use, Technology
Key Market Opportunities Advancements in robotic-assisted surgery enhance precision and patient outcomes in the minimally invasive-surgery-devices market.
Key Market Dynamics Rising demand for advanced minimally invasive surgery devices driven by technological innovations and regulatory support in China.
Countries Covered China
Leave a Comment

FAQs

What is the projected market size of the China Minimally Invasive Surgery Devices Market in 2024?

The projected market size for the China Minimally Invasive Surgery Devices Market in 2024 is 2.75 billion USD.

What will the value of the China Minimally Invasive Surgery Devices Market be by 2035?

The market is expected to reach 4.52 billion USD by the year 2035.

What is the expected compound annual growth rate (CAGR) for the China Minimally Invasive Surgery Devices Market from 2025 to 2035?

The expected CAGR for the China Minimally Invasive Surgery Devices Market from 2025 to 2035 is 4.621%.

Which application segment holds the largest market share in the China Minimally Invasive Surgery Devices Market?

The General Surgery application segment holds the largest market share, valued at 1.05 billion USD in 2024.

What is the market size of the Cardiothoracic Surgery application in 2024?

The market size for the Cardiothoracic Surgery application is valued at 0.7 billion USD in 2024.

Who are the major players in the China Minimally Invasive Surgery Devices Market?

Major players in the market include Medtronic, Boston Scientific, Johnson & Johnson, and Stryker, among others.

What is the projected market size of the Gynecological Surgery segment by 2035?

The Gynecological Surgery segment is projected to reach 0.85 billion USD by 2035.

What factors are driving growth in the China Minimally Invasive Surgery Devices Market?

Increased demand for advanced surgical techniques and cost-efficiency are key drivers of market growth.

How does the Urological Surgery application market size change from 2024 to 2035?

The Urological Surgery application market is expected to grow from 0.3 billion USD in 2024 to 0.55 billion USD in 2035.

What challenges does the China Minimally Invasive Surgery Devices Market face?

Challenges include regulatory hurdles and the need for skilled professionals to operate advanced devices.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions